Novo Nordisk Faces $70M Sales Rep OT Action

Law360, New York (March 5, 2012, 1:50 PM EST) -- A subsidiary of Danish pharmaceutical giant Novo Nordisk A/S was slapped with a $70 million putative class and collective action in New York federal court Monday, which accuses the company of misclassifying its sales representatives as exempt from overtime pay requirements.

Two sales representatives — one current, one former — filed a complaint against Novo Nordisk Inc. that asked for more than $50 million in unpaid wages and liquidated damages under the federal Fair Labor Standards Act, and more than $20 million for violating the New...
To view the full article, register now.